FDA NDC Directory · JSON-LD · Markdown

IMFINZI

NDC 0310-4500 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nameDurvalumab
Labeler / ManufacturerAstraZeneca Pharmaceuticals LP
Marketing categoryBiologic License Application · App BLA761069
Dosage form / routeINJECTION, SOLUTION · INTRAVENOUS
Active ingredientsDURVALUMAB (120 mg/2.4mL)
Marketing started20170501
Package count1

External sources

Source: openFDA. Public-domain (CC0).